石英股份(603688.SH):第四期員工持股計劃已買入149.1597萬股、成交額約1.82億元
格隆匯4月10日丨石英股份(603688.SH)公佈,截止公吿日,公司第四期員工持股計劃已通過“江蘇太平洋石英股份有限公司-第四期員工持股計劃”賬户完成購買公司股票的事項,通過二級市場合計買入公司股票149.1597萬股,佔公司總股本的0.41%,成交均價約人民幣122.18元/股,成交金額為人民幣182,251,760元(含交易費)。此次員工持股計劃授予持有人價格為在二級市場購買公司股票價格的均價。
本員工持股計劃的鎖定期為12個月,自公司公吿完成購買公司最後一筆標的股票之日起算,即自2023年04月11日-2024年04月10日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.